Home › Funds › GLENMEDE TRUST CO NA › APH
GLENMEDE TRUST CO NA position in APH
AMPHENOL CORP · Technology
GLENMEDE TRUST CO NA reported holding 1,298,523 shares of APH (AMPHENOL CORP) in its Q2 2026 13F filing — a position valued at US$229.0M, representing 1.01% of its reported portfolio and ranking #18 among its reported holdings. GLENMEDE TRUST CO NA has disclosed APH holdings in 8 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How GLENMEDE TRUST CO NA's APH position evolved
GLENMEDE TRUST CO NA first disclosed a stake in APH in Q3 2023 at 1,397,439 shares (US$117.4M). The position peaked in Q2 2026 at 1,298,523 shares, worth US$229.0M. Across 8 filings, GLENMEDE TRUST CO NA increased the stake 2 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,298,523 shares valued at US$229.0M — a reduction of -12,828 shares quarter over quarter.. Notable position changes include a 30% increase in Q3 2024 (shares rose 7% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.40M | $117.37M | New |
| Q4 2023 | 1.30M | $128.38M | Reduce |
| Q3 2024 | 1.68M | $109.65M | Add |
| Q4 2024 | 1.60M | $110.94M | Reduce |
| Q1 2025 | 1.67M | $109.33M | Add |
| Q4 2025 | 1.41M | $190.64M | Reduce |
| Q1 2026 | 1.31M | $165.69M | Reduce |
| Q2 2026 | 1.30M | $228.96M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About APH and 13F data
APH (AMPHENOL CORP) is a Technology company. 51 other funds we track also report a position in APH — the largest reported positions include BlackRock Inc (US$17.85B), Fidelity Management & Research (FMR) (US$12.44B), Capital International Investors (US$7.59B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding APH
- BlackRock Inc 101.25M sh · $17.85B · Q2 2026
- Fidelity Management & Research (FMR) 70.57M sh · $12.44B · Q2 2026
- Capital International Investors 43.04M sh · $7.59B · Q2 2026
- JPMorgan Chase & Co 39.20M sh · $6.52B · Q2 2026
- VANGUARD PORTFOLIO MANAGEMENT LLC 35.69M sh · $6.29B · Q2 2026
- PRICE T ROWE ASSOCIATES INC /MD/ 32.01M sh · $5.64B · Q2 2026
- Capital Research Global Investors 29.49M sh · $5.20B · Q2 2026
- Capital Research Global Investors 29.49M sh · $5.20B · Q2 2026
- Wellington Management Group 16.58M sh · $2.92B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 16.58M sh · $2.92B · Q2 2026
- Nuveen, LLC 15.07M sh · $2.66B · Q2 2026
- BNY Mellon 14.57M sh · $2.57B · Q2 2026
More on GLENMEDE TRUST CO NA
FAQ
How long has GLENMEDE TRUST CO NA held APH?
GLENMEDE TRUST CO NA has disclosed APH holdings in 8 of the last 12 reported quarters, going back to Q3 2023.
What is GLENMEDE TRUST CO NA's current position in APH?
As of Q2 2026, GLENMEDE TRUST CO NA holds 1.30M shares of APH (AMPHENOL CORP), valued at $228.96M, representing 1.01% of its reported portfolio and ranking #18.
Has GLENMEDE TRUST CO NA been buying or selling APH?
In the latest 13F filing (Q2 2026), GLENMEDE TRUST CO NA reduced its position in APH. The position peaked in Q2 2026 at 1.30M shares.
Which other funds hold APH?
Other major institutional holders of APH include BlackRock Inc, Fidelity Management & Research (FMR), Capital International Investors, among 51 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.